Publications and Other News

Koirala, M., DiPaola, M. Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment. Biomedicines 2024, 12, 1801

Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment

Koirala, M., DiPaola, M. Targeting CDK9 in Cancer: An Integrated Approach of Combining In-Silico Screening with Experimental Validation for Novel Degraders. Curr. Issues Mol. Biol. 2024, 46, 1713-1730.

https://doi.org/10.3390/cimb46030111

World's Leaders 2023: Mario DiPaola: Creating Legacy in Biotechnology and Pharmaceuticals.

Mario DiPaola: Creating Legacy in Biotechnology and Pharmaceuticals | Co-Founder and CEO at Therebene, Inc

Mario DiPaola: Who's Who of Top Executives

Mario DiPaola, PhD, MBA - Top Execs

First World Pharma, 2024: Therabene Inc. Announces Positive Preclinical Results for Two Promising New Molecules in Collaboration with Biocytogen. 

Therabene Inc. Announces Positive Preclinical Results for Two Promising New Molecules in Collaboration with Biocytogen | FirstWord Pharma                                                                                                                                 

Therabene Inc. Press Release 1: Therabene Inc. Announces Positive Preclinical Results for Two Promising New Molecules in Collaboration with Biocytogen

https://www.accesswire.com/viewarticle.aspx?id=945824

Therabene Inc. Press Release 2: Therabene Inc. Appoints Dr. Oscar L. Kashala as Chief Medical Officer and Executive Vice President of Global Clinical Development

https://www.accessnewswire.com/newsroom/en/biotechnology/therabene-inc.-appoints-dr.-oscar-l.-kashala-as-chief-medical-officer-and-executive-v-1057356